Caffeic acid phenethyl ester exhibiting distinctive binding interaction with human serum albumin implies the pharmacokinetic basis of propolis bioactive components

Journal of Pharmaceutical and Biomedical Analysis

Volumn 122, Issue , 2016, Pages 21-28

  Li, Hongliang ^a,b   Wu, Fan ^b   Tan, Jing ^b   Wang, Kai ^a   Zhang, Cuiping ^a   Zheng, Huoqing ^a   Hu, Fuliang ^a  

^a ZHEJIANG UNIVERSITY   (China)

^b CHINA JILIANG UNIVERSITY   (China)

Author keywords

Binding interaction; Caffeic acid phenethyl ester; Human serum albumin; Molecular docking; Multispectroscopy; Propolis components

Indexed keywords

CAFFEIC ACID; CAFFEIC ACID PHENETHYL ESTER; CHLOROGENIC ACID; CINNAMIC ACID; FERULIC ACID; HUMAN SERUM ALBUMIN; IBUPROFEN; PARA COUMARIC ACID; PROPOLIS; WARFARIN; CAFFEIC ACID DERIVATIVE; PHENETHYL ALCOHOL; PROTEIN BINDING; SERUM ALBUMIN;

ARTICLE; ASSOCIATION CONSTANT; BINDING AFFINITY; BINDING SITE; CIRCULAR DICHROISM; CONFORMATIONAL TRANSITION; CRYSTAL STRUCTURE; DRUG BINDING; DRUG CLEARANCE; DRUG DISTRIBUTION; ENTHALPY; ENTROPY; FLUORESCENCE RESONANCE ENERGY TRANSFER; HIGH TEMPERATURE; HYDROGEN BOND; HYDROPHOBICITY; IN VITRO STUDY; LIGHT ABSORPTION; MOLECULAR DOCKING; PRIORITY JOURNAL; PROTEIN SECONDARY STRUCTURE; PROTEIN UNFOLDING; QUANTUM YIELD; STATIC ELECTRICITY; THERMODYNAMICS; ANALOGS AND DERIVATIVES; CHEMISTRY; HUMAN; PROCEDURES; SPECTROFLUOROMETRY;

CAFFEIC ACIDS; CIRCULAR DICHROISM; FLUORESCENCE RESONANCE ENERGY TRANSFER; HUMANS; HYDROGEN BONDING; MOLECULAR DOCKING SIMULATION; PHENYLETHYL ALCOHOL; PROPOLIS; PROTEIN BINDING; PROTEIN STRUCTURE, SECONDARY; SERUM ALBUMIN; SPECTROMETRY, FLUORESCENCE; THERMODYNAMICS;

EID: 84961371272     PISSN: 07317085     EISSN: 1873264X     Source Type: Journal    
DOI: 10.1016/j.jpba.2016.01.040     Document Type: Article

References (45)

1. Burdock G. Review of the biological properties and toxicity of bee propolis (propolis). Food Chem. Toxicol. 1998, 36:347-363.
2. Chan G.C.-F., Cheung K.-W., Sze D.M.-Y. The immunomodulatory and anticancer properties of propolis. Clin. Rev. Allerg. Immunol. 2013, 44:262-273.
3. Bankova V.S., de Castro S.L., Marcucci M.C. Propolis: recent advances in chemistry and plant origin. Apidologie 2000, 31:3-16.
4. Kujumgiev A., Tsvetkova I., Serkedjieva Y., Bankova V., Christov R., Popov S. Antibacterial, antifungal and antiviral activity of propolis of different geographic origin. J. Ethnopharmacol. 1999, 64:235-240.
5. Akyol S., Ozturk G., Ginis Z., Armutcu F., Yigitoglu M.R., Akyol O. In vivo and in vitro antineoplastic actions of caffeic acid phenethyl ester (CAPE): therapeutic perspectives. Nutr. Cancer 2013, 65:515-526.
6. Sforcin J. Propolis and the immune system: a review. J. Ethnopharmacol. 2007, 113:1-14.
7. Park J.H., Lee J.K., Kim H.S., Chung S.T., Eom J.H., Kim K.A., Chung S.J., Paik S.Y., Oh H.Y. Immunomodulatory effect of caffeic acid phenethyl ester in Balb/c mice. Int. Immunopharmacol. 2004, 4:429-436.
8. Toyoda T., Tsukamoto T., Takasu S., Shi L., Hirano N., Ban H., Kumagai T., Tatematsu M. Anti-inflammatory effects of caffeic acid phenethyl ester (CAPE) a nuclear factor-kappaB inhibitor, on Helicobacter pylori-induced gastritis in Mongolian gerbils. Int. J. Cancer 2009, 125:1786-1795.
9. Chen Y.J., Shiao M.S., Hsu M.L., Tsai T.H., Wang S.Y. Effect of caffeic acid phenethyl ester an antioxidant from propolis, on inducing apoptosis in human leukemic HL-60 cells. J. Agric. Food Chem. 2001, 49:5615-5619.
10. Lee H.S., Chang J.H. Antimicrobial spine-bone cement with caffeic acid phenethyl ester for controlled release formulation and in vivo biological assessments. MedChemComm 2015, 6:327-333.
11. He Y.J., Liu B.H., Xiang D.B., Qiao Z.Y., Fu T., He Y.H. Inhibitory effect of caffeic acid phenethyl ester on the growth of SW480 colorectal tumor cells involves beta-catenin associated signaling pathway down-regulation. World J. Gastroenterol. 2006, 12:4981-4985.
12. Wu J., Omene C., Karkoszka J., Bosland M., Eckard J., Klein C.B., Frenkel K. Caffeic acid phenethyl ester (CAPE) derived from a honeybee product propolis, exhibits a diversity of anti-tumor effects in pre-clinical models of human breast cancer. Cancer Lett. 2011, 308:43-53.
13. Kamiya T., Nishihara H., Hara H., Adachi T. Ethanol extract of Brazilian red propolis induces apoptosis in human breast cancer MCF-7 cells through endoplasmic reticulum stress. J. Agric. Food Chem. 2012, 60:11065-11070.
14. Beltran-Ramirez O., Aleman-Lazarini L., Salcido-Neyoy M., Hernandez-Garcia S., Fattel-Fazenda S., Arce-Popoca E., Arellanes-Robledo J., Garcia-Roman R., Vazquez-Vazquez P., Sierra-Santoyo A., Villa-Trevino S. Evidence that the anticarcinogenic effect of caffeic acid phenethyl ester in the resistant hepatocyte model involves modifications of cytochrome P450. Toxicol. Sci. 2008, 104:100-106.
15. Celli N., Dragani L.K., Murzilli S., Pagliani T., Poggi A. In vitro and in vivo stability of caffeic acid phenethyl ester, a bioactive compound of propolis. J. Agric. Food Chem. 2007, 55:3398-3407.
16. Fanali G., di Masi A., Trezza V., Marino M., Fasano M., Ascenzi P. Human serum albumin: from bench to bedside. Mol. Aspects Med. 2012, 33:209-290.
17. Wei J., Jin F., Wu Q., Jiang Y., Gao D., Liu H. Molecular interaction study of flavonoid derivative 3d with human serum albumin using multispectroscopic and molecular modeling approach. Talanta 2014, 126:116-121.
18. Sudlow G., Birkett D., Wade D. Further characterization of specific drug binding sites on human serum albumin. Mol. Pharmacol. 1976, 12:1052-1061.
19. Fanali G., Bocedi A., Ascenzi P., Fasano M. Modulation of heme and myristate binding to human serum albumin by anti-HIV drugs. FEBS J. 2007, 274:4491-4502.
20. Wang Y., Zhang T., Xu J., Du W. Comparison of the binding affinity of chlorogenic acid with two serum albumins. Int. J. Biol. Macromol. 2011, 48:81-86.
21. Hu T.Y., Liu Y. Probing the interaction of cefodizime with human serum albumin using multi-spectroscopic and molecular docking techniques. J. Pharm. Biomed. Anal. 2015, 107:325-332.
22. Bolli A., Marino M., Rimbach G., Fanali G., Fasano M., Ascenzi P. Flavonoid binding to human serum albumin. Biochem. Biophys. Res. Commun. 2010, 398:444-449.
23. Mukherjee M., Sardar P.S., Ghorai S.K., Samanta S.K., Roy A.S., Dasgupta S., Ghosh S. Interaction of multitryptophan protein with drug: an insight into the binding mechanism and the binding domain by time resolved emission, anisotropy, phosphorescence and docking. J. Photochem. Photobiol. B 2012, 115:93-104.
24. Kang J., Liu Y., Xie M.-X., Li S., Jiang M., Wang Y.-D. Interactions of human serum albumin with chlorogenic acid and ferulic acid. BBA-Gen. Subj. 2004, 1674:205-214.
25. Sinisi V., Forzato C., Cefarin N., Navarini L., Berti F. Interaction of chlorogenic acids and quinides from coffee with human serum albumin. Food Chem. 2015, 168:332-340.
26. Min J., Meng-Xia X., Dong Z., Yuan L., Xiao-Yu L., Xing C. Spectroscopic studies on the interaction of cinnamic acid and its hydroxyl derivatives with human serum albumin. J. Mol. Struct. 2004, 692:71-80.
27. Hu Y.-J., Chen C.-H., Zhou S., Bai A.-M., Ou-Yang Y. The specific binding of chlorogenic acid to human serum albumin. Mol. Biol. Rep. 2012, 39:2781-2787.
28. Laskowski R.A., Swindells M.B. LigPlot+: multiple ligand-protein interaction diagrams for drug discovery. J. Chem. Inf. Model. 2011, 51:2778-2786.
29. DeLano W.L. The PyMOL Molecular Graphics System 2002, DeLano Scientific, San Carlos, CA, USA.
30. Fraiji L.K., Hayes D.M., Werner T. Static and dynamic fluorescence quenching experiments for the physical chemistry laboratory. J. Chem. Educ. 1992, 69:424.
31. Hou H.N., Qi Z.D., Ouyang Y.W., Liao F.L., Zhang Y., Liu Y. Studies on interaction between Vitamin B12 and human serum albumin. J. Pharm. Biomed. Anal. 2008, 47:134-139.
32. Kragh-Hansen U. Structure and ligand binding properties of human serum albumin. Dan. Med. Bull. 1990, 37:57-84.
33. Lakowicz J.R. Principles of Fluorescence Spectroscopy 2007, Springer Science & Business Media.
34. Deepa S., Mishra A.K. Fluorescence spectroscopic study of serum albumin-bromadiolone interaction: fluorimetric determination of bromadiolone. J. Pharm. Biomed. Anal. 2005, 38:556-563.
35. Hall L.M., Hall L.H., Kier L.B. Methods for predicting the affinity of drugs and drug-like compounds for human plasma proteins: a review. Curr. Comput.-Aided Drug 2009, 5:90-105.
36. Curry S. Lessons from the crystallographic analysis of small molecule binding to human serum albumin. Drug Metab. Pharmacokinet. 2009, 24:342-357.
37. Yang Y.H. Caffeic Acid phenethyl ester possessing various immunomodulatory effects is a potentially effective therapy for asthma. Pediatr. Neonatol. 2011, 52:307-308.
38. Miller J.N. Recent advances in molecular luminescence analysis. Proc. Anal. Div. Chem. Soc. 1979, 16:203-208.
39. Stryer L. Fluorescence energy transfer as a spectroscopic ruler. Annu. Rev. Biochem. 1978, 47:819-846.
40. Sharma A., Schulman S.G. Introduction to Fluorescence Spectroscopy 1999, 123-157. John Wiley & Sons, New York.
41. Sandhya B., Hegde A.H., Kalanur S.S., Katrahalli U., Seetharamappa J. Interaction of triprolidine hydrochloride with serum albumins: thermodynamic and binding characteristics and influence of site probes. J. Pharm. Biomed. Anal. 2011, 54:1180-1186.
42. Sugio S., Kashima A., Mochizuki S., Noda M., Kobayashi K. Crystal structure of human serum albumin at 2.5Å resolution. Protein Eng. 1999, 12:439-446.
43. Murtaza G., Karim S., Akram M.R., Khan S.A., Azhar S., Mumtaz A., Bin Asad M.H. Caffeic acid phenethyl ester and therapeutic potentials. Biomed. Res. Int. 2014, 2014:145342.
44. Fanali G., Cao Y., Ascenzi P., Trezza V., Rubino T., Parolaro D., Fasano M. Binding of δ9-tetrahydrocannabinol and diazepam to human serum albumin. IUBMB Life 2011, 63:446-451.
45. Ascenzi P., Bolli A., di Masi A., Tundo G.R., Fanali G., Coletta M., Fasano M. Isoniazid and rifampicin inhibit allosterically heme binding to albumin and peroxynitrite isomerization by heme-albumin. J. Biol. Inorg. Chem. 2010, 16:97-108.